Sydney Morning Herald, April 27, 2016 – 12:01AM
An emergency contraceptive that works up to five days after unprotected sex has been launched by Australia’s sole supplier of medical abortion drug RU486.
The EllaOne pill, from non-profit pharmaceutical group MS Health, is available from Wednesday.
Read more here
New York Times, Feb 22, 2016
A vaccine introduced a decade ago to combat the sexually transmitted virus that causes cervical cancer has already reduced the virus’s prevalence in teenage girls by almost two-thirds, US federal researchers said Monday.
Read more here
nam/aidsmap, 15 February 2016 A group of researchers have cleared up an important question about HIV transmission, in experiments on mice. Although HIV-infected CD4 cells persist in the vagina even on antiretroviral therapy (ART) that fully suppresses free HIV in the blood and body fluids, these cells are not anything like numerous enough to pose any transmission threat. Read more here ...
Hepatitis NSW, 2016 This is a really exciting time if you live in Australia and have hep C. The Federal government has announced that new direct acting antiviral (DAA) treatment drugs will be free and available to you from 1 March 2016. The new treatments are: Harvoni® (sofosbuvir/ledipasvir) two drugs combined in each pill Sovaldi® and Daklinza® (sofosbuvir and daclatasvir) separate pills, taken...
ScienceDaily, December 23, 2015 In one of the most tightly controlled trials ever conducted of drugs used to treat sexually transmitted infections, researchers at the University of Alabama at Birmingham have confirmed that azithromycin remains effective in the treatment of urogenital chlamydia. In a study published Dec. 24 in the New England Journal of Medicine, the research team compared two of...
NAM , 02 December 2015 The results from the Ipergay study of intermittent pre-exposure prophylaxis (PrEP) were published in the New England Journal of Medicine (NEJM) on 1 December, World AIDS Day. The journal-published results are little changed from those presented at the CROI conference last February by principal investigator Jean-Michel Molina, but the researchers make a number of additional...